₹1,592.15 76.10 (5.02%)
03:25 PM, 19-Dec-2024₹1,596.50 83.30 (5.50%)
03:09 PM, 19-Dec-2024BSE : 524494
NSE : IPCALAB
Sector : Health care
ISIN Code : INE571A01038
Last Updated: 19-Dec-2024 | 03:25 PM IST
Market Cap (₹ Cr) | 40,393 |
Traded Value (₹ Cr) | 19.80 |
Volume (Shares) | 1,24,353 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,708.70 |
52-Week High Date | 14-Oct-2024 |
52-Week Low (₹) | 1,042.00 |
52-Week Low Date | 21-Dec-2023 |
All Time High (₹) | 1,708.70 |
All Time High Date | 14-Oct-2024 |
All Time Low (₹) | 2.83 |
All Time Low Date | 18-Sep-2001 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 40,503 |
EPS - TTM (₹) [C] | 26.47 |
P/E Ratio (X) [C] | 60.31 |
Face Value (₹) | 1 |
Latest Dividend (%) | 200.00 |
Latest Dividend Date | 27-Nov-2024 |
Dividend Yield (%) | 0.26 |
Book Value Share (₹) [C] | 264.10 |
P/B Ratio (₹) [C] | 6.05 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
HDFC Mid-Cap Opportunities Fund (G) | 2437.52 | 1,58,01,894 | 3.20 |
HDFC Mid-Cap Opportunities Fund (IDCW) | 2437.52 | 1,58,01,894 | 3.20 |
HDFC Mid-Cap Opportunities Fund - Direct (IDCW) | 2437.52 | 1,58,01,894 | 3.20 |
HDFC Mid-Cap Opportunities Fund - Direct (G) | 2437.52 | 1,58,01,894 | 3.20 |
Kotak Emerging Equity Fund (G) | 1478.97 | 95,87,797 | 2.84 |
Kotak Emerging Equity Fund (IDCW) | 1478.97 | 95,87,797 | 2.84 |
Kotak Emerging Equity Fund - Direct (G) | 1478.97 | 95,87,797 | 2.84 |
Kotak Emerging Equity Fund - Direct (IDCW) | 1478.97 | 95,87,797 | 2.84 |
DSP Midcap Fund (G) | 664.75 | 43,09,410 | 3.46 |
DSP Midcap Fund (IDCW) | 664.75 | 43,09,410 | 3.46 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
01-Oct-2024 | Share Khan | Buy | 1,734 | |
16-Aug-2024 | Share Khan | Buy | 1,600 | |
13-Nov-2023 | Prabhudas Lilladher | Hold | 1,060 | |
21-Feb-2023 | Sharekhan | Hold | 909 |
Today's Low/High (₹) | 1,478.50 1,602.50 |
Week Low/High (₹) | 1,478.50 1,602.50 |
Month Low/High (₹) | 1,470.50 1,622.00 |
Year Low/High (₹) | 1,041.00 1,709.00 |
All time Low/High (₹) | 2.83 1,709.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 2.34% | 2.31% | -2.50 | -2.42% |
1 Month | 1.49% | 1.40% | 2.17 | 1.85% |
3 Month | 9.82% | 9.77% | -4.72 | -5.75% |
6 Month | 40.85% | 40.86% | 2.49 | 1.86% |
1 Year | 44.12% | 44.13% | 10.95 | 11.66% |
3 Year | 60.12% | 60.26% | 39.02 | 41.03% |
Executive Chairman : Premchand Godha
Managing Director & CFO : A K Jain
Managing Director & CEO : Pranay Godha
Executive Director : Prashant Godha
Independent Non Exe. Director : Kamal Kishore Seth
Independent Non Exe. Director : Narendra Mairpady
Company Sec. & Compli. Officer : Harish P Kamath
Independent Director : Swati Patankar
Independent Director : Vivek Shiralkar
Registered Office: 48 Kandivli Industrial Estate, Kandivli (West),Mumbai,Maharashtra-400067 Ph: 91-22-66474444
1. What's the Ipca Laboratories Ltd share price today?
Ipca Laboratories Ltd share price was Rs 1,592.15 at 03:25 PM IST on 19th Dec 2024. Ipca Laboratories Ltd share price was up by 5.02% over the previous closing price of Rs 1,516.05. Ipca Laboratories Ltd share price trend:
2. How can I quickly analyse the performance of the Ipca Laboratories Ltd stock?
The performance of the Ipca Laboratories Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Ipca Laboratories Ltd?
Ipca Laboratories Ltd has a market capitalisation of Rs 40,393 crore.
4. What is Ipca Laboratories Ltd's 52-week high/low share price?
The Ipca Laboratories Ltd’s 52-week high share price is Rs 1,708.70 and 52-week low share price is Rs 1,042.00.
5. Is the Ipca Laboratories Ltd profitable?
On a consolidated basis, Ipca Laboratories Ltd reported a profit of Rs 244.12 crore on a total income of Rs 1,827.94 crore for the quarter ended 2024. For the year ended Sep 2024, Ipca Laboratories Ltd had posted a profit of Rs 245.44 crore on a total income of Rs 2,381.16 crore.
6. Which are Ipca Laboratories Ltd’s peers in the Health care sector?
Ipca Laboratories Ltd’s top 5 peers in the Health care sector are Abbott India, Glenmark Pharma., Biocon, Ipca Labs., Glaxosmi. Pharma, Ajanta Pharma, Piramal Pharma.
7. Who owns how much in Ipca Laboratories Ltd?
Key changes to the Ipca Laboratories Ltd shareholding are as follows: